Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1986;8:30-36

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hunt, S. C.
Right arrow Articles by Ash, K. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hunt, S. C.
Right arrow Articles by Ash, K. O.

Hypertension, Vol 8, 30-36, Copyright © 1986 by American Heart Association


ARTICLES

Associations of three erythrocyte cation transport systems with plasma lipids in Utah subjects

SC Hunt, RR Williams, JB Smith and KO Ash

To investigate the pathophysiology of essential hypertension, detailed biochemical and clinical variables were collected and analyzed for 2091 Utah subjects aged 3 to 83 years. Three different measurements of erythrocyte cation transport were obtained: Na+-Li+ countertransport, Li+-K+ cotransport, and furosemide-insensitive Li+ efflux into MgCl2. Total plasma cholesterol, triglycerides, and high density lipoprotein cholesterol levels were obtained from fasting subjects. Levels of high density lipoprotein subfractions 2 and 3 were also obtained from 350 subjects. Standardized data collection also included blood pressure, height, weight, and presence or absence of a diagnosis or treatment of essential hypertension. In univariate analyses of all 1420 adults, each of the three transport systems showed the same significant correlations with triglyceride levels (r = 0.33-0.35, p less than 0.0001), high density lipoprotein concentration (r = -0.19 to -0.21, p less than 0.001), and weight (r = 0.22-0.28, p less than 0.0001). In multivariate regression analyses, values for each transport system were significantly higher in hypertensive subjects; values for triglycerides, high density lipoprotein, and usually, the high density lipoprotein subfractions continued to have strong significant independent associations with all three transport systems; and weight remained significantly related only to Na+-Li+ countertransport. In separate logistic regressions, plasma triglyceride levels (positively, p less than 0.001) and high density lipoprotein subfraction 3 levels (inversely, p less than 0.03) were associated with hypertension itself. In multivariate analyses among 671 children, high density lipoprotein and high density lipoprotein subfraction 3 levels showed significant (p less than 0.05) inverse correlations with Na+-Li+ countertransport and furosemide-insensitive Li+ efflux.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
ANGIOLOGYHome page
C. G. Savopoulos, A. I. Hatzitolios, N. A. Katsiki, M. Baltatzi, M. Kosmidou, N. Raikos, D. P. Mikhailidis, A. G. Ziakas, G. Kaiafa, and N. Tsesmeli
Sodium-Lithium Countertransport Activity in Healthy, Dyslipidemic, and Hypertensive Individuals
Angiology, January 1, 2009; 59(6): 727 - 735.
[Abstract] [PDF]


Home page
HypertensionHome page
A. B. Weder, M. C. Delgado, X. Zhu, L. Gleiberman, D. Kan, and A. Chakravarti
Erythrocyte Sodium-Lithium Countertransport and Blood Pressure: A Genome-Wide Linkage Study
Hypertension, March 1, 2003; 41(3): 842 - 846.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. J. Schork, J. P. Gardner, L. Zhang, D. Fallin, B. Thiel, H. Jakubowski, and A. Aviv
Genomic Association/Linkage of Sodium Lithium Countertransport in CEPH Pedigrees
Hypertension, November 1, 2002; 40(5): 619 - 628.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Mead, R. Wilkinson, and T. H. Thomas
Thiol Protein Defect in Sodium-Lithium Countertransport in Subset of Essential Hypertension
Hypertension, December 1, 1999; 34(6): 1275 - 1280.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Zicha, Z. Dobesova, and J. Kunes
Plasma Triglycerides and Red Cell Ion Transport Alterations in Genetically Hypertensive Rats
Hypertension, September 1, 1997; 30(3): 636 - 640.
[Abstract] [Full Text]


Home page
CirculationHome page
M. Laurenzi, M. Cirillo, W. Panarelli, M. Trevisan, R. Stamler, A. R. Dyer, and J. Stamler
Baseline Sodium-Lithium Countertransport and 6-Year Incidence of Hypertension: The Gubbio Population Study
Circulation, February 4, 1997; 95(3): 581 - 587.
[Abstract] [Full Text]


Home page
HypertensionHome page
Y. Chi, D. M. de Freitas, M. Sikora, and V. K. Bansal
Correlations of Na+-Li+ Exchange Activity With Na+ and Li+ Binding and Phospholipid Composition in Erythrocyte Membranes of White Hypertensive and Normotensive Individuals : A Nuclear Magnetic Resonance Investigation
Hypertension, March 1, 1996; 27(3): 456 - 464.
[Abstract] [Full Text]


Home page
HypertensionHome page
O. Giampietro, E. Matteucci, G. Catapano, G. Dell'Omo, L. Talarico, C. Di Muro, V. Di Bello, and R. Pedrinelli
Microalbuminuria and Erythrocyte Sodium-Hydrogen Exchange in Essential Hypertension
Hypertension, May 1, 1995; 25(5): 981 - 985.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
D. M. Cummings, P. Amadio Jr, L. Nelson, and J. M. Fitzgerald
The Role of Calcium Channel Blockers in the Treatment of Essential Hypertension
Arch Intern Med, February 1, 1991; 151(2): 250 - 259.
[Abstract] [PDF]


Home page
JAMAHome page
R. R. Williams, S. C. Hunt, P. N. Hopkins, B. M. Stults, L. L. Wu, S. J. Hasstedt, G. K. Barlow, S. H. Stephenson, J.-M. Lalouel, and H. Kuida
Familial Dyslipidemic Hypertension: Evidence From 58 Utah Families for a Syndrome Present in Approximately 12% of Patients With Essential Hypertension
JAMA, June 24, 1988; 259(24): 3579 - 3586.
[Abstract] [PDF]